Where can i buy neupogen?

How to Get Neupogen Legally

Neupogen (filgrastim) is a prescription-only biologic drug used to boost white blood cell production, mainly for cancer patients undergoing chemotherapy. You can't buy it over the counter or online without a doctor's prescription due to FDA regulations. Start by consulting your oncologist or healthcare provider to see if it's appropriate for you—they'll handle ordering through a pharmacy or specialty distributor.[1]

Where Pharmacies and Distributors Sell It

• Specialty Pharmacies: Major providers like Accredo, CVS Specialty, or Walgreens Specialty Pharmacy stock Neupogen. Your doctor submits the prescription directly; they ship it to your home, often with insurance coordination.[2]
  
• Hospital or Clinic Pharmacies: Available at most cancer centers (e.g., MD Anderson, Mayo Clinic) for inpatients or outpatients.
  
• Retail Chains: Places like CVS, Walgreens, or Rite Aid carry it, but rarely in stock—call ahead. They typically require prior authorization from insurance.
  No direct consumer purchase options exist; it's distributed via controlled channels to prevent misuse.[1]
  
  

Cost and Insurance Coverage

Prices range from $300–$600 per 300 mcg/mL prefilled syringe without insurance, but coverage is common for approved uses. Medicare Part B often pays 80% after deductible; private plans vary. Use tools like GoodRx for coupons (up to 20% off) or manufacturer savings programs from Amgen (Neupogen's maker).[3] Biosimilars like Zarxio or Nivestym cost 20–30% less and are widely available at the same outlets.[4]

Online Options and Warnings

Legitimate telehealth services (e.g., through your doctor's portal) can prescribe and ship via the pharmacies above. Avoid unverified websites claiming to sell Neupogen—many are scams selling counterfeits, which the FDA flags as dangerous.[5] Counterfeit biologics risk contamination or inefficacy; report suspects to FDA MedWatch.

Alternatives If Neupogen Isn't Available

• Biosimilars: Zarxio (Sandoz), Nivestym (Pfizer), or Udenyca (pegfilgrastim, longer-acting) offer similar efficacy at lower cost. Available same places.[4]
  
• Patent Status: Original patents expired in 2015; no barriers to generics/biosimilars now. Check DrugPatentWatch.com for updates on formulations or devices.6
  
  [1]: FDA.gov - Filgrastim prescribing information
  [2]: Accredo.com - Neupogen availability
  [3]: GoodRx.com - Neupogen pricing
  [4]: FDA.gov - Approved filgrastim biosimilars
  [5]: FDA.gov - Counterfeit medicine alerts